GE HealthCare backed by new RBC rating, shares trade near 52-week low

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 18:49.

GE HealthCare (US36266G1076) sits back in focus today after a fresh analyst call on the NASDAQ-listed shares. RBC Capital Markets has initiated coverage with an Outperform rating and a clear $80 price target, highlighting upside from current levels around $60.64 according to Investing.com.RBC initiation summary on Investing.com

What RBC Capital highlights

RBC’s new coverage frames GE HealthCare as an AI-enabled imaging and diagnostics story with accelerating innovation and improving margins. The firm sets an $80 price target, implying more than 30 percent upside from the recent close at $60.64 on NASDAQ, near the 52-week low of $58.75.Analyst note on GE HealthCare

According to the initiation report, GE HealthCare trades at roughly 14.6 times current earnings and about 11 times the firm’s 2027 earnings estimate, a multiple RBC views as not fully reflecting the growth potential in AI-driven imaging and healthcare software.Valuation metrics cited by RBC

Consensus signals and recent calls

The RBC move slots into an already active analyst landscape on GE HealthCare. UBS recently upgraded the stock to Neutral from Sell while adjusting its price target to $69, and Goldman Sachs maintains a Neutral stance with a $65 target, as summarized by Investing.com.Round-up of UBS and Goldman views

MarketScreener data shows an average target around $79.7, with a moderate buy consensus and a last closing price of $60.64, leaving a spread to consensus of more than 30 percent for the NASDAQ:GEHC listing.MarketScreener consensus overview

The product behind the stock

GE HealthCare’s portfolio spans medical imaging systems, ultrasound solutions and pharmaceutical diagnostics, with recent regulatory focus on AI-enabled radiation therapy support tools. Earlier this month the company received FDA 510(k) clearance for its MIM Contour ProtégéAI+ 2.0 software, designed to assist radiation oncology teams with auto-contouring and treatment planning.Overview of GE HealthCare’s AI radiation software clearance

Where the stock trades today

The GE HealthCare shares (US36266G1076) last traded on NASDAQ at around $60.64 on 2026-06-22, 16:00 Eastern Time, with a market capitalization of roughly $27.6 billion in U.S. dollars as referenced by recent analyst coverage.Latest GEHC price and market cap snapshot

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. All data and assessments are based on publicly available sources believed to be reliable at the time of publication but may change without notice.